Lipid metabolism and cancer progression: The missing target in metastatic cancer treatment

Journal of Applied Biomedicine

Volumn 13, Issue 1, 2015, Pages 47-59

  Omabe, Maxwell ^a,b   Ezeani, Martin ^b   Omabe, Kenneth Nwobini ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b EBONYI STATE UNIVERSITY   (Nigeria)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Adipocytes; Breast cancer; Cytokines; Fatty acid synthase; Glycolysis; Inflammation; Oxidative phosphorylation; Palmitate; Prostate cancer; Tumorigenesis

Indexed keywords

2 HYDROXYGLUTARIC ACID; ADIPOCYTOKINE; FATTY ACID; FATTY ACID SYNTHASE; FUMARATE HYDRATASE; GLUCOSE; ISOCITRATE DEHYDROGENASE; LIPID; PALMITIC ACID; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUCCINATE DEHYDROGENASE; SUCCINIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANAEROBIC GLYCOLYSIS; APOPTOSIS; BREAST CANCER; BROWN ADIPOSE TISSUE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL HYPOXIA; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CITRIC ACID CYCLE; CYTOKINE RELEASE; DISEASE ASSOCIATION; FATTY ACID SYNTHESIS; GAIN OF FUNCTION MUTATION; GLUCOSE METABOLISM; HUMAN; LEUKEMIA; LIPID MEMBRANE; LOSS OF FUNCTION MUTATION; MACROPHAGE; METASTASIS; MITOCHONDRIAL RESPIRATION; REVIEW; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT; WHITE ADIPOSE TISSUE;

EID: 84925955033     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.1016/j.jab.2014.09.004     Document Type: Review

References (58)

1. Adam, J., Yang, M., Soga, T., Pollard, P.J., 2014. Rare insights into cancer biology. Oncogene 33, 2547-2556.
2. Aldhafiri, F.K., McColl, J.H., Reilly, J.J., 2014. Prognostic significance of being overweight and obese at diagnosis in children with acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 36, 234-236.
3. Baillargeon, J., Langevin, A.M., Lewis, M., Estrada, J., Mullins, J., Pitney, A., Ma, J.Z., Chisholm, G.B., Pollock, B.H., 2006. Obesity and survival in a cohort of predominantly Hispanic children with acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 28, 575-578.
4. Besnard, V., Xu, Y., Whitsett, J.A., 2007. Sterol response element binding protein and thyroid transcription factor-1 (Nkx2.1) regulate Abca3 gene expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1395-L1405.
5. Brown, M.S., Goldstein, J.L., 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47.
6. Butturini, A.M., Dorey, F.J., Lange, B.J., Henry, D.W., Gaynon, P.S., Fu, C., Franklin, J., Siegel, S.E., Seibel, N.L., Rogers, P.C., Sather, H., Trigg, M., Bleyer, W.A., Carroll, W.L., 2007. Obesity and outcome in pediatric acute lymphoblastic leukemia. J. Clin. Oncol. 25, 2063-2069.
7. Cheng, C.S., Wang, Z., Chen, J., 2014. Targeting FASN in breast cancer and the discovery of promising inhibitors from natural products derived from Traditional Chinese Medicine. Evid. Based Compl. Alternat. Med. 2014, 232946.
8. Cleary, M.P., Grossmann, M.E., Ray, A., 2010. Effect of obesity on breast cancer development. Vet. Pathol. 47, 202-213.
9. De Schrijver, E., Brusselmans, K., Heyns, W., Verhoeven, G., Swinnen, J.V., 2003. RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res. 63, 3799-3804.
10. Dirat, B., Bochet, L., Dabek, M., Daviaud, D., Dauvillier, S., Majed, B., Wang, Y.Y., Meulle, A., Salles, B., Le Gonidec, S., Garrido, I., Escourrou, G., Valet, P., Muller, C., 2011. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 71, 2455-2465.
11. Fiorentino, M., Zadra, G., Palescandolo, E., Fedele, G., Bailey, D., Fiore, C., Nguyen, P.L., Migita, T., Zamponi, R., Di Vizio, D., Priolo, C., Sharma, C., Xie, W., Hemler, M.E., Mucci, L., Giovannucci, E., Finn, S., Loda, M., 2008. Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer. Lab. Invest. 88, 1340-1348.
12. Fiorio, E., Mercanti, A., Terrasi, M., Micciolo, R., Remo, A., Auriemma, A., Molino, A., Parolin, V., Di Stefano, B., Bonetti, F., Giordano, A., Cetto, G.L., Surmacz, E., 2008. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis. BMC Cancer 8, 305.
13. Gabitova, L., Gorin, A., Astsaturov, I., 2014. Molecular pathways: sterols and receptor signaling in cancer. Clin. Cancer Res. 20, 28-34.
14. Galluzzi, L., Kepp, O., Vander Heiden, M.G., Kroemer, G., 2013. Metabolic targets for cancer therapy. Nat. Rev. Drug Discov. 12, 829-846.
15. Garofalo, C., Koda, M., Cascio, S., Sulkowska, M., Kanczuga-Koda, L., Golaszewska, J., Russo, A., Sulkowski, S., Surmacz, E., 2006. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesityrelated stimuli. Clin. Cancer Res. 12, 1447-1453 PMID: 16533767.
16. Grossmann, M.E., Ray, A., Nkhata, K.J., Malakhov, D.A., Rogozina, O.P., Dogan, S., Cleary, M.P., 2010. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 29, 641-653 PMID: 20821253.
17. Guo, D., Prins, R.M., Dang, J., Kuga, D., Iwanami, A., Soto, H., Lin, K.Y., Huang, T.T., Akhavan, D., Hock, M.B., Zhu, S., Kofman, A.A., et al., 2009. EGFR signaling through an Akt-SREBP-1- dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. Sci. Signal. 2, ra82.
18. Guo, D., Reinitz, F., Youssef, M., Hong, C., Nathanson, D., Akhavan, D., Kuga, D., Amzajerdi, A.N., Soto, H., Zhu, S., Babic, I., Tanaka, K., et al., 2011. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discov. 1, 442-456.
19. Hijiya, N., Panetta, J.C., Zhou, Y., Kyzer, E.P., Howard, S.C., Jeha, S., Razzouk, B.I., Ribeiro, R.C., Rubnitz, J.E., Hudson, M.M., Sandlund, J.T., Pui, C.H., Relling, M.V., 2006. Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia. Blood 108, 3997-4002.
20. Hopperton, K.E., Duncan, R.E., Bazinet, R.P., Archer, M.C., 2014. Fatty acid synthase plays a role in cancer metabolism beyond providing fatty acids for phospholipid synthesis or sustaining elevations in glycolytic activity. Exp. Cell Res. 320, 302-310.
21. Juge-Aubry, C.E., Henrichot, E., Meier, C.A., 2005. Adipose tissue: a regulator of inflammation, Best Practice and Research. Clin. Endocrinol. Metabol. 19, 547-566.
22. Kridel, S.J., Lowther, W.T., Pemble IV, C.W., 2007. Fatty acid synthase inhibitors: new directions for oncology. Expert Opin. Investig. Drugs 16, 1817-1829.
23. Larsson, S.C., Wolk, A., 2008. Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies. Int. J. Cancer 122, 1418-1421.
24. Larsson, S.C., Wolk, A., 2011. Body mass index and risk of non- Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur. J. Cancer 47, 2422-2430.
25. Lautenbach, A., Budde, A., Wrann, C.D., Teichmann, B., Vieten, G., Karl, T., Nave, H., 2009. Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutr. Cancer 61, 484-491 PMID: 19838920.
26. Lee, J.S., Lee, M.S., Oh, W.K., Sul, J.Y., 2009. Fatty acid synthase inhibition by amentoflavone induces apoptosis and antiproliferation in human breast cancer cells. Biol. Pharm. Bull. 32, 1427-1432.
27. Liu, H., Liu, J.Y., Wu, X., Zhang, J.T., 2010. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int. J. Biochem. Mol. Biol. 1, 69-89.
28. Louie, S.M., Roberts, L.S., Mulvihill, M.M., Luo, K., Nomura, D.K., 2013. Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids. Biochim. Biophys. Acta 1831, 1566-1572.
29. Lu, C.W., Lin, S.C., Chen, K.F., Lai, Y.Y., Tsai, S.J., 2008. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J. Biol. Chem. 283, 28106-28114.
30. Lupu, R., Menendez, J.A., 2006. Pharmacological inhibitors of Fatty Acid Synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr. Pharm. Biotechnol. 7, 483-493.
31. Medes, G., Thomas, A., Weinhouse, S., 1953. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 13, 27-29.
32. Menendez, J.A., Mehmi, I., Atlas, E., Colomer, R., Lupu, R., 2004. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Int. J. Oncol. 24, 591-608.
33. Menendez, J.A., Vellon, L., Colomer, R., Lupu, R., 2005. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. Int. J. Cancer 115 (May), 19-35.
34. Moschetta, A., 2011. Nuclear receptor LXR as a novel therapeutic antitumoral target in glioblastoma. Cancer Discov. 1 (October), 381-382.
35. Nair, S., Al-Hendy, A., 2011. Adipocytes enhance the proliferation of human leiomyoma cells via TNF-a proinflammatory cytokine. Reprod. Sci. 18, 1186-1192 PMID: 22096007.
36. Nair, S., Nguyen, H., Salama, S., Al-Hendy, A., 2013. Obesity and the endometrium: adipocyte-secreted proinflammatory TNF a cytokine enhances the proliferation of human endometrial glandular cells. Obstet. Gynecol. Int. 2013, 368543 PMID: 24288542.
37. Nieman, K.M., Kenny, H.A., Penicka, C.V., Ladanyi, A., Buell- Gutbrod, R., Zillhardt, M.R., Romero, I.L., Carey, M.S., Mills, G. B., Hotamisligil, G.S., Yamada, S.D., Peter, M.E., Gwin, K., Lengyel, E., 2011. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498-1503.
38. Omabe, M., Kenneth, N.O., 2014. Insight in inflammation and cancer. Atlas Genet. Cytogenet. Oncol. Haematol. 18, 203-216.
39. Omabe Maxwell, Chinwe Ewenighi, Martin Ezeani, gbonnaya Kenneth, Uzor Simon, Okike Omabe, J.C., Onyeanusi, Nnatuanya1, I.N., Onoh, L.U.M., 2011. Tumor hypoxia and treatment resistant prostate cancer. J. Med. Med. Sci. 2, 1306-1312.
40. Omabe, M., Odii, B.O., 2013. 2013 Dissecting The Biology of Solid Tumor: The Microenvironment and Cancer Progression. Br. J. Med. Med. Res. 3, 1786-1797.
41. Omabe, M., Ezeani, M., Donatus, U., 2013. Metabolic basis of treatment failures; autophagy and malignant cancer progression. J. Clin. Exp. Oncol. 2, 3.
42. Pramanik, R., Sheng, X., Ichihara, B., Heisterkamp, N., Mittelman, S.D., 2013. Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy. Leuk. Res. 37, 503-509.
43. Ribeiro, R., Monteiro, C., Cunha, V., Oliveira, M.J., Freitas, M., Fraga, A., Príncipe, P., Lobato, C., Lobo, F., Morais, A., Silva, V., Sanches-Magalhães, J., Oliveira, J., Pina, F., Mota-Pinto, A., Lopes, C., Medeiros, R., 2012. Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro. J. Exp. Clin. Cancer Res. 31, 32.
44. Ross, J.S., Fletcher, J.A., 1999. The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy. Semin. Cancer Biol. 9, 125-138.
45. Schlichtholz, B., Turyn, J., Goyke, E., Biernacki, M., Jaskiewicz, K., Sledzinski, Z., Swierczynski, J., 2005. Enhanced citrate synthase activity in human pancreatic cancer. Pancreas 30, 99-104.
46. Schmidt, L.J., Ballman, K.V., Tindall, D.J., 2007. Inhibition of fatty acid synthase activity in prostate cancer cells by dutasteride. Prostate 67, 1111-1120.
47. Shah, U.S., Dhir, R., Gollin, S.M., Chandran, U.R., Lewis, D., Acquafondata, M., Pflug, B.R., 2006. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum. Pathol. 37, 401-409.
48. Suganami, T., Ogawa, Y., 2010. Adipose tissue macrophages: their role in adipose tissue remodeling. J. Leukoc. Biol. 88, 33-39.
49. Suganami, T., Nishida, J., Ogawa, Y., 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25, 2062-2068 PMID: 16123319.
50. Surmacz, E., 2007. Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res. 9, 301.
51. Vazquez-Martin, A., Colomer, R., Brunet, J., Lupu, R., Menendez, J.A., 2008. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif. 41, 59-85.
52. Vazquez-Martin, A., Colomer, R., Brunet, J., Menendez, J.A., 2007. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells. Int. J. Oncol. 31, 769-776.
53. Vazquez-Martin, A., Fernandez-Real, J.M., Oliveras-Ferraros, C., Navarrete, J.M., Martin-Castillo, B., Del Barco, S., Brunet, J., Menendez, J.A., 2009. Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients. Int. J. Oncol. 35, 1369-1376.
54. Vicente Lòpez, À., Vàzquez García, M.N., Melen, G.J., Entrena Martínez, A., Cubillo Moreno, I., García-Castro, J., Orellana, M. R., Gonzàlez, A.G., 2014. Mesenchymal stromal cells derived from the bone marrow of acute lymphoblastic leukemia patients show altered BMP4 production: correlations with the course of disease. PLoS One 9, e84496.
55. Wang, Z., Wang, N., Chen, J., Shen, J., 2012. Emerging glycolysis targeting and drug discovery from Chinese medicine in cancer therapy. Evid. Based Compl. Alternat. Med. 2012, 873175.
56. Warburg, O., 1956. On the origin of cancer cells. Science 123, 309-314.
57. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., Ferrante Jr., A.W., 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 PMID: 14679176.
58. Yarden, Y., Sliwkowski, M.X., 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127-137.